United States:
Novel Pyrrolo[3,2-D]Pyrimidine Compounds Target Mitochondrial And Cytosolic One-Carbon Metabolism With Broad-Spectrum Antitumor Efficacy
26 July 2019
Kramer Levin Naftalis & Frankel LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Intellectual Property scientific advisor Khushbu Shah
co-authored an article titled “Novel Pyrrolo[3,2-d]Pyrimidine
Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism
with Broad-Spectrum Antitumor Efficacy” which was published
in AACR Journals on July 9, 2019. The article describes
structure-activity relationships and identifies exciting new drug
prototypes for development as multi-targeted antitumor agents.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...